← Back to Search

e-CBT for Generalized Anxiety Disorder

N/A
Waitlist Available
Led By Nazanin Alavi, MD, FRCPC
Research Sponsored by Dr. Nazanin Alavi
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 0, week 6, week 12, 6-month follow-up
Awards & highlights

Study Summary

This trial will compare the efficacy of an electronically-delivered cognitive behavioural therapy (e-CBT) program to a mental health coaching program to treat generalized anxiety disorder (GAD).

Who is the study for?
This trial is for adults aged 18-65 with Generalized Anxiety Disorder (GAD) as per DSM-5, who can understand English and have reliable internet access. It's not suitable for those with active psychosis, severe substance abuse, suicidal thoughts, ongoing psychotherapy or acute mania.Check my eligibility
What is being tested?
The study compares an online cognitive behavioural therapy program (e-CBT) to a mental health coaching program in treating GAD. Over 12 weeks, participants will either engage in e-CBT modules with therapist feedback or weekly themed chats through the platform.See study design
What are the potential side effects?
While there are no direct side effects from participating in e-CBT or mental health coaching programs themselves, discussing anxiety might temporarily increase distress or emotional discomfort.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 0, week 6, week 12, 6-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 0, week 6, week 12, 6-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in symptoms (Depression Anxiety Scale - 42 Item)
Change in symptoms (Generalized Anxiety Disorder - 7 Item)
Change in symptoms (Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form)
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: e-CBTExperimental Treatment1 Intervention
12 weekly sessions of approximately 30 slides and interactive content, delivered through OPTT. The e-CBT module content mirrors in-person standard CBT content, including different weekly topics, general information, skill overviews, and homework. Participants are instructed to go through the content and complete homework at the end of the session which helps them practice skills they learned through that session. Homework is submitted through OPTT and reviewed by the therapist assigned to the participant, who will provide personalized feedback within three days of submission. Therapists have access to pre-designed session-specific feedback templates to use as a basic structure to write their feedback. By doing so, the time needed to respond to each patient is reduced and therefore the number of patients each therapist can handle increases.
Group II: Mental Health CoachingExperimental Treatment1 Intervention
Weekly interactions with the therapist using general questions on the following topics: Week 1 (Mood) Week 2 (Sleep) Week 3 (Activity) Week 4 (Hobbies) Week 5 (Friendship) Week 6 (New Events) Week 7 (Job/Study) Week 8 (Diet/Food) Week 9 (Books/Movies/Shows) Week 10 (Phone/Apps/Games) Week 11 (Habits) Week 12 (Accomplishments)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
e-CBT
2021
N/A
~200

Find a Location

Who is running the clinical trial?

Dr. Nazanin AlaviLead Sponsor
12 Previous Clinical Trials
1,016 Total Patients Enrolled
1 Trials studying Generalized Anxiety Disorder
115 Patients Enrolled for Generalized Anxiety Disorder
Queen's UniversityLead Sponsor
365 Previous Clinical Trials
120,317 Total Patients Enrolled
4 Trials studying Generalized Anxiety Disorder
285 Patients Enrolled for Generalized Anxiety Disorder
Nazanin Alavi, MD, FRCPCPrincipal InvestigatorQueen's University
1 Previous Clinical Trials
79 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I fulfill the requirements to be a part of this experiment?

"This trial is seeking 100 participants aged 18 to 65 with anxiety disorders. To be eligible, patients must demonstrate their capacity for informed consent and meet the age requirements of the study."

Answered by AI

Do older adults, aged 35 and above, qualify for this research?

"The parameters for a successful application to this trial rely on the individual being between 18 and 65 years old. There are 147 trials available for those below the age of consent, while 441 opportunities exist for seniors over 65."

Answered by AI

Are there any open recruitment opportunities for this experiment?

"According to the clinicaltrials.gov database, this research is still in need of participants. The trial was initiated on April 1st 2021 and the information was recently updated on October 5th 2022."

Answered by AI

How many participants are being monitored in this research experiment?

"Affirmative. According to clinicaltrials.gov, the trial which was initially posted on April 1st 2021 is currently looking for participants. It aims to enroll 100 individuals across a single medical centre."

Answered by AI

Who else is applying?

How old are they?
18 - 65
What site did they apply to?
Hotel Dieu Hospital
What portion of applicants met pre-screening criteria?
Met criteria
What state do they live in?
Manitoba
~25 spots leftby Apr 2025